Tofacitinib Ameliorates Lipopolysaccharide-Induced Acute Kidney Injury by Blocking the JAK-STAT1/STAT3 Signaling Pathway

Figure 1

Experimental schedule. Mice were administered LPS (10 mg/kg) or vehicle via intraperitoneal injection. One hour later, TOFA (5, 10, or 15 mg/kg) or vehicle was given via gavage every 6 h until sacrifice at 24 h.